Ginsenoside-Rb1 as an anti-cancer therapeutic: abridged secondary publication
AST Wong1, CKC Wong2
1 School of Biological Sciences, The University of Hong Kong
2 Department of Biology, Hong Kong Baptist University
1. Ginsenoside Rb1 and its derivative compound K target cancer stem cells.
2. Ginsenoside Rb1 and compound K chemosensitise cancer stem cells to chemotherapeutic drugs.
3. Wnt/β-catenin signalling causes the ensuing cytotoxic effects.